Leaders come together to discuss latest advances in neurosciences

NewsGuard 100/100 Score

Stony Brook Medicine's Neurosciences Institute brings together leaders in the field of neurosciences to present the latest advances in research and clinical care for neurodegenerative disorders, neuropsychiatric disorders, and neuro-ophthalmology. The "Meeting of the Minds" Symposium will be held at the Charles B. Wang Center at Stony Brook University on November 9, 2012.

The symposium is designed for physicians, researchers, students, and other healthcare professionals with a special interest in the field of neurosciences. Continuing Medical Education credits are earned by participating physicians and nurses.

The keynote speaker is Helen S. Mayberg, MD, Professor, Psychiatry, Neurology and Radiology, Emory University School of Medicine. Dr. Mayberg will present "Rethinking Depression and its Treatment: Insights from Studies of Deep Brain Stimulation."

Dr.Mayberg recently appeared on CNN discussing "Treating depression with electrodes inside the brain."Other Meeting of the Minds Symposium highlights include presentations by Stony Brook University Neurosciences Institute faculty. These interactive sessions include: "Neurosurgery in Sub-Saharan Africa: Tanzania Neurosurgery Project," by Robert Galler, MD, DO; "Amyotrophic Lateral Sclerosis (ALS): Past, Present, Future," by Nurcan Gursoy, MD, PhD; and "Alzheimer's Disease: A Protein Folding Disorder," by William Van Nostrand, PhD.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Renaissance of "food as medicine" in modern clinical trials